Neuropathological aspects of SARS-CoV-2 infection: significance for both Alzheimer’s and Parkinson’s disease

Simple item page
dc.audiencegeneralPublices_MX
dc.contributor.authorSilva, Jaime
dc.contributor.authorPatricio, Felipe
dc.contributor.authorPatricio Martinez, Aleidy
dc.contributor.authorSantos López, Gerardo
dc.contributor.authorCedillo, Lilia
dc.contributor.authorTizabi, Yousef
dc.contributor.authorLimón, Ilhuicamina Daniel
dc.creatorPATRICIO MARTINEZ, ALEIDY; 350139
dc.date.accessioned2023-02-02T18:43:11Z
dc.date.available2023-02-02T18:43:11Z
dc.date.issued2022-05-03
dc.description.abstract"Evidence suggests that SARS-CoV-2 entry into the central nervous system can result in neurological and/or neurodegenerative diseases. In this review, routes of SARS-Cov-2 entry into the brain via neuroinvasive pathways such as transcribrial, ocular surface or hematogenous system are discussed. It is argued that SARS-Cov-2-induced cytokine storm, neuroinflammation and oxidative stress increase the risk of developing neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Further studies on the effects of SARS-CoV-2 and its variants on protein aggregation, glia or microglia activation, and blood-brain barrier are warranted".es_MX
dc.identifierhttps://doi.org/10.3389/fnins.2022.867825
dc.identifier.urihttps://hdl.handle.net/20.500.12371/17311
dc.language.isospaes_MX
dc.rights.accesopenAccesses_MX
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0es_MX
dc.subject.otherSARS-CoV-2es_MX
dc.subject.otherAlzheimer’s diseasees_MX
dc.subject.otherParkinson’s diseasees_MX
dc.subject.otherNeuroinvasive pathwayses_MX
dc.subject.otherBlood-brain barrieres_MX
dc.titleNeuropathological aspects of SARS-CoV-2 infection: significance for both Alzheimer’s and Parkinson’s diseasees_MX
dc.typeArtículoes_MX
dc.type.conacytarticle
Files
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Investigadoras BUAP